Alvotech (ALVOW) Comparison with companies in other sectors?

Alvotech has a share price of 1.42B. You can analyze Alvotech (ALVOW) competitors across different market sectors through stock heatmaps.

What are ALVOW's NET and operating margins?

Alvotech (ALVOW) operating margin is around 0.22, and net profit margin is approximately 0.16 as of the latest reports.

In what way does ALVOW's earnings per share (EPS) trend reflect its financial momentum?

Alvotech (ALVOW) EPS is N/A (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Alvotech is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Alvotech?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Alvotech like P/E which is 27.72, P/B which is -8.85, and PEG which is 0.20. Compare them with sector averages to evaluate if the stock is priced fairly.

Alvotech

ALVOW•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$2.66

$0.77(40.52%)

Fundamental Analysis of Alvotech (ALVOW)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

P/E Ratio

ROE

-0.23%

Net Margin

0.16%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.05B

Shares OutstandingTotal number of shares issued

$1.42B

Book Value/ShareNet worth per share

$-1.07

Revenue/ShareAnnual revenue per share

$2.08

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

Net MarginNet income as percentage of revenue

16.49%

Operating MarginOperating income as percentage of revenue

21.97%

ROEReturn on shareholders' equity

-23.20%

ROAReturn on total assets

7.75%

ROCEReturn on capital employed

13.13%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.80

Cash/ShareCash and equivalents per share

$0.14

FCF YieldFree cash flow as percentage of market cap

-7.78%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for ALVOWFinancial Ratios Analysis details for ALVOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ALVOWSector Benchmarking details for ALVOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Alvotech Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Alvotech. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Alvotech's unique business strengths and challenges.

Key Financial Metrics for Alvotech

For Alvotech, essential financial indicators include EPS -, PE -, and ROE -0.23. These key ratios reveal insights into Alvotech's profitability, valuation, and operational health. Understanding these metrics enables you to compare Alvotech with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Alvotech

Metrics like Net Margin 16.49% and ROA 7.75% shed light on how well Alvotech is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Alvotech can sustain its operations and continue growing in the future.

Valuation and Market Position of Alvotech

Using ratios such as P/B Ratio -8.85 and PEG Ratio 0.20, investors can assess whether Alvotech is appropriately valued based on its financials and growth potential. These figures, combined with Alvotech's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Alvotech

Financial health indicators, such as Debt/Equity Ratio -4.06 and Cash Flow $-0.80, provide a snapshot of Alvotech's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Alvotech, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Alvotech

Investing in Alvotech based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Alvotech focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;